Clomethiazole (chlormethiazole, Zendra®) is undergoing phase III clinical investigation with Astra in Europe, the USA and Canada for the treatment of acute stroke. It is currently being used clinically to treat seizures, alcohol withdrawal and as a sedative. Although the mechanism of action of clomethiazole is not fully understood, studies suggest that it may act by stimulating the GABA receptor.